Möchten Sie immer auf dem neuesten Stand bleiben?

SHELTON, Conn., July 23, 2025 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) today announced that net sales for the quarter ended June 30, 2025 were $54.0 million compared to $55.4...

Landmark approval is based on results from the Phase 3 AQUILA study, showing fixed-duration treatment with daratumumab significantly reduced the risk of progression to active multiple myeloma or death...

Ibrutinib is the first approved Bruton’s tyrosine kinase (BTK) inhibitor to demonstrate statistically meaningful outcomes versus autologous stem cell transplant (ASCT) for the frontline treatment of...

Order intake at €4.1 billion. Rolling Stock book-to-bill ratio back at 1.0xSales at €4.5 billion, up 2.8% vs. last year, of which 7.2% organicFiscal year 2025/26 outlook and medium-term ambitions...

Approval based on INAVO120 data showing the Itovebi™ (inavolisib)-based regimen more than doubled progression-free survival compared with palbociclib and fulvestrant alone1 Up to 40% of ER-positive...

GUADALAJARA, Mexico, July 22, 2025 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) reports its consolidated results for the second...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, July 22, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Red Cat Holdings, Inc. ("Red...

Eupraxia Pharmaceuticals Invited to Present at Upcoming Investor Conferences

GREEN COVE SPRINGS, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- MDWerks, Inc. (“MDWerks” or the “Company”) (OTCQB: MDWK), a forward-thinking company leading the charge in the world of sustainable...

Norwood Financial Corp (Nasdaq Global Market-NWFL) and its subsidiary, Wayne Bank, announced results for the three months and six months ended June 30.